TKL Research, a full-service CRO, has officially opened its new primary research clinic in Fair Lawn, N.J. This 25,000-square-foot facility offers a 70% increase in space over TKL’s former clinic, making it possible to create a sophisticated 30-bed phase I pharmacology unit and multiple examination rooms for outpatient studies.

The central location allows access to the Northern New Jersey/New York medical communities, ease in travel for sponsors and patients, broadening TKL’s reach when recruiting for various clinical studies.

“The Fair Lawn research facility will enable us to meet the increased demand for our services in the diseased-state populations for phase I clinical trials in which we have strong patient recruitment expertise,” said Jon C. Anderson, Ph.D., TKL Research president and CEO.

The expanded capabilities include two configurable male/female dormitories, a centralized nurses’ station, two dedicated infusion wards, a comprehensive biopharmaceutical laboratory and a dedicated dermatology research clinic.